High-definition Transcranial Electrical Stimulation for Upper Extremity Rehabilitation
- Disease/Condition
- Stroke
- Drug/Device/Intervention
- HD-tES
- Study type
- Interventional
- Intervention type
- device
- Primary sponsor
- National Taiwan University Hospital
- Location
- New Taipei City,Taipei,Taipei, Taiwan
- Phase
- N/A
- Start date
- Jun 01, 2024
- End date
- Nov 30, 2026
- Enrollment
- 152 participants
Pre- and 3-month change in motor function of the upper limbs assessed by Fugl-Meyer Assessment of Upper Extremity (FMA-UE),Pre- and 3-month change in motor function of the upper limbs assessed by Action Research Arm Test (ARAT)
Upper limb hemiparesis is the most common sequelae in patients, severely impacting their
 independence and quality of life. Transcranial electrical stimulation (tCES) is a
 non-invasive and safe treatment, which uses a low direct current or alternating current to
 change the excitability of the cerebral cortex. It can induces long-term potentiation-like or
 long-term depression-like effects, thereby modulating the cortical excitability. In recent
 years, researchers have developed high-definition (HD) devices, which integrate high
 definition ring electrode configurations and incorporate direct current with theta burst
 stimulation waveforms. Diverging from traditional transcranial direct current stimulation
 (tDCS), which applies weak currents (0.5-2 mA) through two large sponge electrodes (25~35
 cm^2) externally to the scalp for widespread non-specific cortical stimulation, HD-tES
 employs an array of small-area electrodes (1 cm^2) to control current distribution over
 localized cortical regions, thereby enhancing spatial accuracy. However, there is a lack of
 studies validating the optimal waveform for HD-tES, as well as clinical evidence in subacute
 stroke populations. The optimal unilateral versus bilateral stimulation modes and their
 neurological mechanisms for stroke rehabilitation also remain uncertain.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06409143
- Type
- Device Trial
Access comprehensive clinical trial information for NCT06409143 through Pure Global AI's free database. This phase not specified trial is sponsored by National Taiwan University Hospital and is currently Not yet recruiting. The study focuses on Stroke. Target enrollment is 152 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.